LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Strausz, Satu"
  2. AU="Defanti, Carlo Alberto"
  3. AU="Vyse, Timothy J"
  4. AU="Appel, Robson Mateus"
  5. AU="Masahiro Yasunaga"
  6. AU="Westphal, Joachim"
  7. AU="Zhiqi, Huang"
  8. AU="Acevedo, A C"
  9. AU="García-Cenador, Begoña"
  10. AU="Wisecup, Ciara"
  11. AU="Scortti, Mariela"
  12. AU="Allen, David M."
  13. AU="Martínez, J Alfredo"

Suchergebnis

Treffer 1 - 10 von insgesamt 11

Suchoptionen

  1. Artikel ; Online: Genetic analysis of probable sleep bruxism and its associations with clinical and behavioral traits.

    Strausz, Tommi / Strausz, Satu / Palotie, Tuula / Ahlberg, Jari / Ollila, Hanna M

    Sleep

    2023  Band 46, Heft 10

    Abstract: Study objectives: Sleep bruxism (SB) can cause damage on teeth, headache and severe pain affecting both sleep and daily functioning. Yet despite the growing interest into bruxism, the underlying clinically relevant biological mechanisms remain ... ...

    Abstract Study objectives: Sleep bruxism (SB) can cause damage on teeth, headache and severe pain affecting both sleep and daily functioning. Yet despite the growing interest into bruxism, the underlying clinically relevant biological mechanisms remain unresolved. The aim of our study was to understand biological mechanisms and clinical correlates of SB including previously reported disease associations.
    Methods: We used data from the FinnGen release R9 (N = 377 277 individuals) that are linked with Finnish hospital and primary care registries. We identified 12 297 (3.26%) individuals with International Classification of Diseases (ICD)-10 codes used for SB. In addition, we used logistic regression to examine the association between probable SB and its clinically diagnosed risk factors and comorbidities using ICD-10 codes. Furthermore, we examined medication purchases using prescription registry. Finally, we performed the first genome-wide association analysis for probable SB and computed genetic correlations using questionnaire, lifestyle, and clinical traits.
    Results: The genome-wide association analysis revealed one significant association: rs10193179 intronic to Myosin IIIB (MYO3B) gene. In addition, we observed phenotypic associations and high genetic correlations with pain diagnoses, sleep apnea, reflux disease, upper respiratory diseases, psychiatric traits, and also their related medications such as antidepressants and sleep medication (p < 1e-4 for each trait).
    Conclusions: Our study provides a large-scale genetic framework to understand risk factors for SB and suggests potential biological mechanisms. Furthermore, our work strengthens the important earlier work that highlights SB as a trait that is associated with multiple axes of health. As part of this study, we provide genome-wide summary statistics that we hope will be useful for the scientific community studying SB.
    Sprache Englisch
    Erscheinungsdatum 2023-05-04
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 424441-2
    ISSN 1550-9109 ; 0161-8105
    ISSN (online) 1550-9109
    ISSN 0161-8105
    DOI 10.1093/sleep/zsad107
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Genetic Analysis of Obstructive Sleep Apnea and Its Relationship with Severe COVID-19.

    Strausz, Satu / Agafonova, Elizabete / Tiullinen, Varvara / Kiiskinen, Tuomo / Broberg, Martin / Ruotsalainen, Sanni E / Koskela, Jukka / Bachour, Adel / Sofer, Tamar / Gottlieb, Daniel J / Palotie, Aarno / Palotie, Tuula / Ripatti, Samuli / Ollila, Hanna M

    Annals of the American Thoracic Society

    2024  

    Abstract: Rationale: While patients with obstructive sleep apnea (OSA) have a higher risk for COVID-19 hospitalization, the causal relationship has remained unexplored.: Objectives: To understand the causal relationship between OSA and COVID-19 leveraging data ...

    Abstract Rationale: While patients with obstructive sleep apnea (OSA) have a higher risk for COVID-19 hospitalization, the causal relationship has remained unexplored.
    Objectives: To understand the causal relationship between OSA and COVID-19 leveraging data from vaccination and electronic health records, genetic risk factors from genome-wide association studies (GWAS) and Mendelian randomization.
    Methods: We elucidated genetic risk factors for OSA using FinnGen (N total = 377,277 individuals) performing genome-wide association. We used the associated variants as instruments for univariate and multivariate Mendelian randomization (MR) analyses and computed absolute risk reduction (ARR) against COVID-19 hospitalization with or without vaccination.
    Measurements and main results: We identified 9 novel loci for OSA and replicated our findings in the Million Veterans Program. Furthermore, MR analysis showed that OSA was a causal risk factor for severe COVID-19 (P=9.41x10-4). Probabilistic modelling showed that the strongest genetic risk factor for OSA at the FTO locus reflected a signal of higher BMI, whereas BMI independent association was seen with the earlier reported SLC9A4 locus and a MECOM locus which is a transcriptional regulator with 210-fold enrichment in the Finnish population. Similarly, Multivariate MR (MVMR) analysis showed that the causality for severe COVID-19 was driven by body mass index (BMI), (P MVMR = 5.97x10-6, beta=0.47). Finally, vaccination reduced the risk for COVID-19 hospitalization more in the OSA patients than in the non-OSA controls: ARR = 13.3% vs. ARR = 6.3% in the OSA vs. non-OSA population.
    Conclusions: Our analysis identified novel genetic risk factors for OSA and showed that OSA is a causal risk factor for severe COVID-19. The effect is predominantly explained by higher BMI and suggests BMI-dependent effects at the level of individual variants and at the level of comorbid causality.
    Sprache Englisch
    Erscheinungsdatum 2024-02-08
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2717461-X
    ISSN 2325-6621 ; 1943-5665 ; 2325-6621
    ISSN (online) 2325-6621 ; 1943-5665
    ISSN 2325-6621
    DOI 10.1513/AnnalsATS.202303-215OC
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Large registry-based analysis of genetic predisposition to tuberculosis identifies genetic risk factors at HLA.

    Tervi, Anniina / Junna, Nella / Broberg, Martin / Jones, Samuel E / Strausz, Satu / Kreivi, Hanna-Riikka / Heckman, Caroline A / Ollila, Hanna M

    Human molecular genetics

    2022  Band 32, Heft 1, Seite(n) 161–171

    Abstract: Tuberculosis is a significant public health concern resulting in the death of over 1 million individuals each year worldwide. While treatment options and vaccines exist, a substantial number of infections still remain untreated or are caused by treatment ...

    Abstract Tuberculosis is a significant public health concern resulting in the death of over 1 million individuals each year worldwide. While treatment options and vaccines exist, a substantial number of infections still remain untreated or are caused by treatment resistant strains. Therefore, it is important to identify mechanisms that contribute to risk and prognosis of tuberculosis as this may provide tools to understand disease mechanisms and provide novel treatment options for those with severe infection. Our goal was to identify genetic risk factors that contribute to the risk of tuberculosis and to understand biological mechanisms and causality behind the risk of tuberculosis. A total of 1895 individuals in the FinnGen study had International Classification of Diseases-based tuberculosis diagnosis. Genome-wide association study analysis identified genetic variants with statistically significant association with tuberculosis at the human leukocyte antigen (HLA) region (P < 5e-8). Fine mapping of the HLA association provided evidence for one protective haplotype tagged by HLA DQB1*05:01 (P = 1.82E-06, OR = 0.81 [CI 95% 0.74-0.88]), and predisposing alleles tagged by HLA DRB1*13:02 (P = 0.00011, OR = 1.35 [CI 95% 1.16-1.57]). Furthermore, genetic correlation analysis showed association with earlier reported risk factors including smoking (P < 0.05). Mendelian randomization supported smoking as a risk factor for tuberculosis (inverse-variance weighted P < 0.05, OR = 1.83 [CI 95% 1.15-2.93]) with no significant evidence of pleiotropy. Our findings indicate that specific HLA alleles associate with the risk of tuberculosis. In addition, lifestyle risk factors such as smoking contribute to the risk of developing tuberculosis.
    Mesh-Begriff(e) Humans ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Tuberculosis/genetics ; HLA-DQ beta-Chains/genetics ; HLA-DRB1 Chains/genetics ; Haplotypes/genetics ; Risk Factors ; Alleles ; Gene Frequency
    Chemische Substanzen HLA-DQ beta-Chains ; HLA-DRB1 Chains
    Sprache Englisch
    Erscheinungsdatum 2022-08-26
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1108742-0
    ISSN 1460-2083 ; 0964-6906
    ISSN (online) 1460-2083
    ISSN 0964-6906
    DOI 10.1093/hmg/ddac212
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections.

    Jones, Samuel E / Maisha, Fahrisa I / Strausz, Satu J / Lammi, Vilma / Cade, Brian E / Tervi, Anniina / Helaakoski, Viola / Broberg, Martin E / Lane, Jacqueline M / Redline, Susan / Saxena, Richa / Ollila, Hanna M

    EBioMedicine

    2023  Band 93, Seite(n) 104630

    Abstract: Background: Poor sleep is associated with an increased risk of infections and all-cause mortality but the causal direction between poor sleep and respiratory infections has remained unclear. We examined if poor sleep contributes as a causal risk factor ... ...

    Abstract Background: Poor sleep is associated with an increased risk of infections and all-cause mortality but the causal direction between poor sleep and respiratory infections has remained unclear. We examined if poor sleep contributes as a causal risk factor to respiratory infections.
    Methods: We used data on insomnia, influenza and upper respiratory infections (URIs) from primary care and hospital records in the UK Biobank (N ≈ 231,000) and FinnGen (N ≈ 392,000). We computed logistic regression to assess association between poor sleep and infections, disease free survival hazard ratios, and performed Mendelian randomization analyses to assess causality.
    Findings: Utilizing 23 years of registry data and follow-up, we discovered that insomnia diagnosis associated with increased risk for infections (FinnGen influenza Cox's proportional hazard (CPH) HR = 4.34 [3.90, 4.83], P = 4.16 × 10
    Interpretation: Our findings indicate that chronic poor sleep is a causal risk factor for contracting respiratory infections, and in addition contributes to the severity of respiratory infections. These findings highlight the role of sleep in maintaining sufficient immune response against pathogens.
    Funding: Instrumentarium Science Foundation, Academy of Finland, Signe and Ane Gyllenberg Foundation, National Institutes of Health.
    Mesh-Begriff(e) Humans ; Influenza, Human/complications ; Influenza, Human/epidemiology ; Sleep Initiation and Maintenance Disorders ; Public Health ; COVID-19/complications ; COVID-19/epidemiology ; Respiratory Tract Infections/complications ; Respiratory Tract Infections/epidemiology ; Sleep ; Mendelian Randomization Analysis ; Genome-Wide Association Study ; Polymorphism, Single Nucleotide
    Sprache Englisch
    Erscheinungsdatum 2023-06-08
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article
    ZDB-ID 2851331-9
    ISSN 2352-3964
    ISSN (online) 2352-3964
    DOI 10.1016/j.ebiom.2023.104630
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: SCGB1D2 inhibits growth of Borrelia burgdorferi and affects susceptibility to Lyme disease.

    Strausz, Satu / Abner, Erik / Blacker, Grace / Galloway, Sarah / Hansen, Paige / Feng, Qingying / Lee, Brandon T / Jones, Samuel E / Haapaniemi, Hele / Raak, Sten / Nahass, George Ronald / Sanders, Erin / Soodla, Pilleriin / Võsa, Urmo / Esko, Tõnu / Sinnott-Armstrong, Nasa / Weissman, Irving L / Daly, Mark / Aivelo, Tuomas /
    Tal, Michal Caspi / Ollila, Hanna M

    Nature communications

    2024  Band 15, Heft 1, Seite(n) 2041

    Abstract: Lyme disease is a tick-borne disease caused by bacteria of the genus Borrelia. The host factors that modulate susceptibility for Lyme disease have remained mostly unknown. Using epidemiological and genetic data from FinnGen and Estonian Biobank, we ... ...

    Abstract Lyme disease is a tick-borne disease caused by bacteria of the genus Borrelia. The host factors that modulate susceptibility for Lyme disease have remained mostly unknown. Using epidemiological and genetic data from FinnGen and Estonian Biobank, we identify two previously known variants and an unknown common missense variant at the gene encoding for Secretoglobin family 1D member 2 (SCGB1D2) protein that increases the susceptibility for Lyme disease. Using live Borrelia burgdorferi (Bb) we find that recombinant reference SCGB1D2 protein inhibits the growth of Bb in vitro more efficiently than the recombinant protein with SCGB1D2 P53L deleterious missense variant. Finally, using an in vivo murine infection model we show that recombinant SCGB1D2 prevents infection by Borrelia in vivo. Together, these data suggest that SCGB1D2 is a host defense factor present in the skin, sweat, and other secretions which protects against Bb infection and opens an exciting therapeutic avenue for Lyme disease.
    Mesh-Begriff(e) Mice ; Animals ; Humans ; Borrelia burgdorferi/genetics ; Lyme Disease/microbiology ; Ixodes/microbiology ; Secretoglobins
    Chemische Substanzen SCGB1D2 protein, human ; Secretoglobins
    Sprache Englisch
    Erscheinungsdatum 2024-03-19
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-024-45983-9
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel: The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections.

    Jones, Samuel E / Maisha, Fahrisa I / Strausz, Satu J / Cade, Brian E / Tervi, Anniina M / Helaakoski, Viola / Broberg, Martin E / Lammi, Vilma / Lane, Jacqueline M / Redline, Susan / Saxena, Richa / Ollila, Hanna M

    medRxiv : the preprint server for health sciences

    2022  

    Abstract: Background: Poor sleep is associated with an increased risk of infections and all-cause mortality, and acute sleep loss and disruption have been linked with inflammation and poorer immune control. Previous studies, however, have been unable to evidence ... ...

    Abstract Background: Poor sleep is associated with an increased risk of infections and all-cause mortality, and acute sleep loss and disruption have been linked with inflammation and poorer immune control. Previous studies, however, have been unable to evidence causality between the chronic effects of poor sleep and respiratory infection risk. In light of the ongoing COVID-19 pandemic and potential future disease outbreaks, understanding the risk factors for these infections is of great importance.
    Aim: Our goal was to understand if chronic poor sleep could be identified as a causal risk factor for respiratory infections including influenza, upper respiratory infections and COVID-19.
    Methods: We used population cohorts from the UK Biobank (N ≈ 231,000) and FinnGen (N ≈ 327,000) with ICD-10 based electronic health records and obtained diagnoses of insomnia, influenza and upper respiratory infections (URIs) from primary care and hospital settings. We computed logistic regression to assess association between poor sleep and infections, disease free survival hazard ratios, and used summary statistics from genome-wide association studies of insomnia, influenza, URI and COVID-19 to perform Mendelian randomization analyses and assess causality.
    Findings: Utilizing 23 years of registry data and follow-up, we saw that insomnia diagnosis associated with increased risk for infections in FinnGen and in UK Biobank (FinnGen influenza HR = 5.32 [4.09, 6.92], P = 1.02×10
    Conclusions: Our findings indicate that chronic poor sleep is a causal risk factor for contracting respiratory infections, and in addition contributes to the severity of respiratory infections. These findings highlight the role of sleep in maintaining sufficient immune response against pathogens as suggested by earlier work. As the current COVID-19 pandemic has increased the number of people suffering from poor sleep, safe interventions such as sleep management and treating individuals with insomnia could be promoted to reduce infections and save lives.
    Sprache Englisch
    Erscheinungsdatum 2022-02-17
    Erscheinungsland United States
    Dokumenttyp Preprint
    DOI 10.1101/2022.02.16.22271055
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Sleep apnoea is a risk factor for severe COVID-19.

    Strausz, Satu / Kiiskinen, Tuomo / Broberg, Martin / Ruotsalainen, Sanni / Koskela, Jukka / Bachour, Adel / Palotie, Aarno / Palotie, Tuula / Ripatti, Samuli / Ollila, Hanna M

    BMJ open respiratory research

    2021  Band 8, Heft 1

    Abstract: Background: Obstructive sleep apnoea (OSA) is associated with higher body mass index (BMI), diabetes, older age and male gender, which are all risk factors for severe COVID-19.We aimed to study if OSA is an independent risk factor for COVID-19 infection ...

    Abstract Background: Obstructive sleep apnoea (OSA) is associated with higher body mass index (BMI), diabetes, older age and male gender, which are all risk factors for severe COVID-19.We aimed to study if OSA is an independent risk factor for COVID-19 infection or for severe COVID-19.
    Methods: OSA diagnosis and COVID-19 infection were extracted from the hospital discharge, causes of death and infectious diseases registries in individuals who participated in the FinnGen study (n=260 405). Severe COVID-19 was defined as COVID-19 requiring hospitalisation. Multivariate logistic regression model was used to examine association. Comorbidities for either COVID-19 or OSA were selected as covariates. We performed a meta-analysis with previous studies.
    Results: We identified 445 individuals with COVID-19, and 38 (8.5%) of them with OSA of whom 19 out of 91 (20.9%) were hospitalised. OSA associated with COVID-19 hospitalisation independent from age, sex, BMI and comorbidities (p-unadjusted=5.13×10
    Conclusion: Risk for contracting COVID-19 was the same for patients with OSA and those without OSA. In contrast, among COVID-19 positive patients, OSA was associated with higher risk for hospitalisation. Our findings are in line with earlier works and suggest OSA as an independent risk factor for severe COVID-19.
    Mesh-Begriff(e) Aged ; COVID-19/epidemiology ; Comorbidity ; Female ; Finland/epidemiology ; Humans ; Male ; Middle Aged ; Registries ; Risk Factors ; SARS-CoV-2 ; Severity of Illness Index ; Sleep Apnea, Obstructive/epidemiology
    Sprache Englisch
    Erscheinungsdatum 2021-01-12
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2736454-9
    ISSN 2052-4439 ; 2052-4439
    ISSN (online) 2052-4439
    ISSN 2052-4439
    DOI 10.1136/bmjresp-2020-000845
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections

    Jones, Samuel E. / Maisha, Fahrisa I. / Strausz, Satu J. / Cade, Brian E. / Tervi, Anniina M. / Helaakoski, Viola / Broberg, Martin E. / Lammi, Vilma / FinnGen / Lane, Jacqueline M. / Redline, Susan / Saxena, Richa / Ollila, Hanna M.

    medRxiv

    Abstract: ... Background ... Poor sleep is associated with an increased risk of infections and all-cause mortality, and acute sleep loss and disruption have been linked with inflammation and poorer immune control. Previous studies, however, have been unable to ... ...

    Abstract Background Poor sleep is associated with an increased risk of infections and all-cause mortality, and acute sleep loss and disruption have been linked with inflammation and poorer immune control. Previous studies, however, have been unable to evidence causality between the chronic effects of poor sleep and respiratory infection risk. In light of the ongoing COVID-19 pandemic and potential future disease outbreaks, understanding the risk factors for these infections is of great importance. Aim Our goal was to understand if chronic poor sleep could be identified as a causal risk factor for respiratory infections including influenza, upper respiratory infections and COVID-19. Methods We used population cohorts from the UK Biobank (N ≈ 231,000) and FinnGen (N ≈ 327,000) with ICD-10 based electronic health records and obtained diagnoses of insomnia, influenza and upper respiratory infections (URIs) from primary care and hospital settings. We computed logistic regression to assess association between poor sleep and infections, disease free survival hazard ratios, and used summary statistics from genome-wide association studies of insomnia, influenza, URI and COVID-19 to perform Mendelian randomization analyses and assess causality. Findings Utilizing 23 years of registry data and follow-up, we saw that insomnia diagnosis associated with increased risk for infections in FinnGen and in UK Biobank (FinnGen influenza HR = 5.32 [4.09, 6.92], P = 1.02×10<sup>-35</sup>, UK Biobank influenza HR = 1.54 [1.37, 1.73], P = 2.49×10<sup>-13</sup>). Mendelian randomization indicated that insomnia causally predisposed to influenza (OR = 1.59, P = 6.23×10<sup>-4</sup>), upper respiratory infections (OR = 1.71, P = 7.60×10<sup>-13</sup>), COVID-19 infection (OR = 1.08, P = 0.037) and risk of hospitalization from COVID-19 (OR = 1.47, P = 4.96×10<sup>-5</sup>). Conclusions Our findings indicate that chronic poor sleep is a causal risk factor for contracting respiratory infections, and in addition contributes to the severity of respiratory infections. These findings highlight the role of sleep in maintaining sufficient immune response against pathogens as suggested by earlier work. As the current COVID-19 pandemic has increased the number of people suffering from poor sleep, safe interventions such as sleep management and treating individuals with insomnia could be promoted to reduce infections and save lives.
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2022-02-17
    Verlag Cold Spring Harbor Laboratory Press
    Dokumenttyp Artikel ; Online
    DOI 10.1101/2022.02.16.22271055
    Datenquelle COVID19

    Kategorien

  9. Artikel ; Online: Genetic analysis of obstructive sleep apnoea discovers a strong association with cardiometabolic health.

    Strausz, Satu / Ruotsalainen, Sanni / Ollila, Hanna M / Karjalainen, Juha / Kiiskinen, Tuomo / Reeve, Mary / Kurki, Mitja / Mars, Nina / Havulinna, Aki S / Luonsi, Elina / Mansour Aly, Dina / Ahlqvist, Emma / Teder-Laving, Maris / Palta, Priit / Groop, Leif / Mägi, Reedik / Mäkitie, Antti / Salomaa, Veikko / Bachour, Adel /
    Tuomi, Tiinamaija / Palotie, Aarno / Palotie, Tuula / Ripatti, Samuli

    The European respiratory journal

    2021  Band 57, Heft 5

    Abstract: There is currently limited understanding of the genetic aetiology of obstructive sleep apnoea (OSA). We aimed to identify genetic loci associated with OSA risk, and to test if OSA and its comorbidities share a common genetic background.We conducted the ... ...

    Abstract There is currently limited understanding of the genetic aetiology of obstructive sleep apnoea (OSA). We aimed to identify genetic loci associated with OSA risk, and to test if OSA and its comorbidities share a common genetic background.We conducted the first large-scale genome-wide association study of OSA using the FinnGen study (217 955 individuals) with 16 761 OSA patients identified using nationwide health registries.We estimated 0.08 (95% CI 0.06-0.11) heritability and identified five loci associated with OSA (p<5.0×10
    Mesh-Begriff(e) Alpha-Ketoglutarate-Dependent Dioxygenase FTO ; Body Mass Index ; Diabetes Mellitus, Type 2 ; Genome-Wide Association Study ; Humans ; Hypertension ; Risk Factors ; Sleep Apnea, Obstructive
    Chemische Substanzen Alpha-Ketoglutarate-Dependent Dioxygenase FTO (EC 1.14.11.33) ; FTO protein, human (EC 1.14.11.33)
    Sprache Englisch
    Erscheinungsdatum 2021-05-06
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.03091-2020
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Sleep apnoea is a risk factor for severe COVID-19

    Strausz, Satu / Kiiskinen, Tuomo / Broberg, Martin / Ruotsalainen, Sanni / Koskela, Jukka / Bachour, Adel / Palotie, Aarno / Palotie, Tuula / Ripatti, Samuli / Ollila, Hanna M

    medRxiv

    Abstract: Objective: To investigate if obstructive sleep apnoea (OSA) is an independent risk factor for severe COVID-19. To examine whether the risk for contracting COVID-19 is elevated among OSA patients. Design and setting: Registry based retrospective case- ... ...

    Abstract Objective: To investigate if obstructive sleep apnoea (OSA) is an independent risk factor for severe COVID-19. To examine whether the risk for contracting COVID-19 is elevated among OSA patients. Design and setting: Registry based retrospective case-control study using Finnish nationwide health registries and the FinnGen Study cohort. Participants: Information regarding OSA diagnosis and COVID-19 infection was extracted from the FinnGen study (N=260,405) with a total of 305 patients who had a recorded PCR-validated COVID-19 infection including 26 (8.5%) individuals who were also OSA patients. Severe COVID-19 (N=83, 27.2%) was defined as an infection requiring hospitalization. Among the hospitalized individuals there were 16 (19.3%) with OSA diagnosis. In addition, we also included in our analysis previously reported risk factors for both severe COVID-19 or risk factors and comorbidities for OSA from FinnGen. Main outcome measures: OSA diagnosis, information concerning COVID-19 infection such as hospitalization, were derived from Finnish National Hospital Discharge Registry, Causes of Death Registry and the National Infectious Diseases Registry. Results: We show that OSA is a risk factor for COVID-19 hospitalization independent from age, sex, body mass index (BMI), hypertension, diabetes, coronary heart disease (CHD), asthma and chronic obstructive pulmonary disease (COPD), (p-unadjusted=1.04x10^-4, OR-adjusted=5.24 [95%CI 1.33 to 23.43], p-adjusted=0.022). OSA was not associated with the risk of contracting COVID-19 (p=0.49). Conclusion: While an OSA patients risk of contracting COVID-19 is the same as non-OSA individuals, the OSA patients have a five-fold risk to be hospitalized when affected by COVID-19 than non-OSA individuals. Our findings suggest that, in assessment of patients with suspected or confirmed COVID-19 infection, OSA needs to be recognized as one of the comorbidity risk factors for developing a severe form of the disease.
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-09-28
    Verlag Cold Spring Harbor Laboratory Press
    Dokumenttyp Artikel ; Online
    DOI 10.1101/2020.09.26.20202051
    Datenquelle COVID19

    Kategorien

Zum Seitenanfang